Promoting access to biosimilars: a public−private partnership model for biosimilar development in underserved populations

Timothy Mackey
2012 GaBI Journal  
Biologicals represent the future of pharmaceutical treatments and innovation. Yet, emerging and developing markets lack access to these often essential medicines. Biosimilar development represents a potential solution to this problem, by off ering lower cost and improved access, but is also associated with patient safety issues. In order to synergize these divergent challenges, targeted public−private partnerships that bring together shared goals and resources of the public sector, global fi
more » ... , and local manufacturers need to be explored. Crucial to their success will be equitable intellectual property rights management and coordination and collaboration with eff ective governance and incentives.
doi:10.5639/gabij.2012.0102.018 fatcat:5yb3kd2ruraqtb7otuqdnbcoam